Annual CFI
-$171.67 M
-$210.86 M-538.10%
31 December 2023
Summary:
Acumen Pharmaceuticals annual cash flow from investing activities is currently -$171.67 million, with the most recent change of -$210.86 million (-538.10%) on 31 December 2023. During the last 3 years, it has fallen by -$171.67 million (-100.00%). ABOS annual CFI is now -538.10% below its all-time high of $39.19 million, reached on 31 December 2022.ABOS Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$10.13 M
-$47.83 M-126.88%
30 September 2024
Summary:
Acumen Pharmaceuticals quarterly cash flow from investing activities is currently -$10.13 million, with the most recent change of -$47.83 million (-126.88%) on 30 September 2024. Over the past year, it has increased by +$81.87 million (+88.99%). ABOS quarterly CFI is now -118.12% below its all-time high of $55.92 million, reached on 30 September 2022.ABOS Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$30.44 M
+$81.87 M+72.89%
30 September 2024
Summary:
Acumen Pharmaceuticals TTM cash flow from investing activities is currently -$30.44 million, with the most recent change of +$81.87 million (+72.89%) on 30 September 2024. Over the past year, it has increased by +$112.84 million (+78.75%). ABOS TTM CFI is now -161.38% below its all-time high of $49.59 million, reached on 30 September 2022.ABOS TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABOS Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -538.1% | +89.0% | +78.8% |
| 3 y3 years | -100.0% | +89.2% | +67.7% |
| 5 y5 years | - | - | - |
ABOS Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -538.1% | at low | -118.1% | +89.2% | -161.4% | +82.3% |
| 5 y | 5 years | -538.1% | at low | -118.1% | +89.2% | -161.4% | +82.3% |
| alltime | all time | -538.1% | at low | -118.1% | +89.2% | -161.4% | +82.3% |
Acumen Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$10.13 M(-126.9%) | -$30.44 M(-72.9%) |
| June 2024 | - | $37.70 M(-509.6%) | -$112.31 M(-19.2%) |
| Mar 2024 | - | -$9.20 M(-81.1%) | -$138.95 M(-19.1%) |
| Dec 2023 | -$171.67 M(-538.1%) | -$48.81 M(-46.9%) | -$171.67 M(+19.8%) |
| Sept 2023 | - | -$92.00 M(-931.5%) | -$143.28 M(-3190.7%) |
| June 2023 | - | $11.06 M(-126.4%) | $4.64 M(+96.7%) |
| Mar 2023 | - | -$41.93 M(+105.3%) | $2.36 M(-94.0%) |
| Dec 2022 | $39.19 M | -$20.42 M(-136.5%) | $39.19 M(-21.0%) |
| Sept 2022 | - | $55.92 M(+536.5%) | $49.59 M(-149.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | $8.79 M(-272.3%) | -$100.43 M(-8.0%) |
| Mar 2022 | - | -$5.10 M(-49.1%) | -$109.22 M(+4.9%) |
| Dec 2021 | -$104.12 M(<-9900.0%) | -$10.01 M(-89.4%) | -$104.12 M(+10.6%) |
| Sept 2021 | - | -$94.10 M(>+9900.0%) | -$94.11 M(>+9900.0%) |
| June 2021 | - | -$6000.00(<-9900.0%) | -$6000.00(<-9900.0%) |
| Mar 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2020 | $0.00 | - | - |
| Dec 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2020 | - | $0.00 | $0.00 |
FAQ
- What is Acumen Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Acumen Pharmaceuticals?
- What is Acumen Pharmaceuticals annual CFI year-on-year change?
- What is Acumen Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Acumen Pharmaceuticals?
- What is Acumen Pharmaceuticals quarterly CFI year-on-year change?
- What is Acumen Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Acumen Pharmaceuticals?
- What is Acumen Pharmaceuticals TTM CFI year-on-year change?
What is Acumen Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of ABOS is -$171.67 M
What is the all time high annual CFI for Acumen Pharmaceuticals?
Acumen Pharmaceuticals all-time high annual cash flow from investing activities is $39.19 M
What is Acumen Pharmaceuticals annual CFI year-on-year change?
Over the past year, ABOS annual cash flow from investing activities has changed by -$210.86 M (-538.10%)
What is Acumen Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of ABOS is -$10.13 M
What is the all time high quarterly CFI for Acumen Pharmaceuticals?
Acumen Pharmaceuticals all-time high quarterly cash flow from investing activities is $55.92 M
What is Acumen Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, ABOS quarterly cash flow from investing activities has changed by +$81.87 M (+88.99%)
What is Acumen Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of ABOS is -$30.44 M
What is the all time high TTM CFI for Acumen Pharmaceuticals?
Acumen Pharmaceuticals all-time high TTM cash flow from investing activities is $49.59 M
What is Acumen Pharmaceuticals TTM CFI year-on-year change?
Over the past year, ABOS TTM cash flow from investing activities has changed by +$112.84 M (+78.75%)